Biomedical Science Letters

eISSN 2288-7415

Download original image
Fig. 2.

Phospho-Rab10 level was reduced by LRRK2 kinase inhibitor treatment in murine BV2 microglial cells. Five days after seeding, the cells were treated with or without Pam3CSK4 (P3C4, 400 ng/mL), a TLR2 ligand, and GSK2578215A (3 μM) for 24 h. A. A representative of western blot analysis after the indicated treatment. (*nonspecific band; n=3) B. C. Relative densitometric levels of pS935-LRRK2 which were normalized to α-tubulin (B) and pRab10/Rab10 (C). *P<0.05.

Biomed Sci Letters 2019;25:177-84 https://doi.org/10.15616/BSL.2019.25.2.177
© 2019 Biomed Sci Letters